Chilton Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-110
Closed -$10.7K 543
2023
Q1
$10.7K Buy
+110
New +$10.7K ﹤0.01% 452